Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Acute Antibody-Mediated Rejection (AMR)”

5 trials

Showing 5 of 5 results

Large-scale testing (Phase 3)Ended earlyNCT02547220
What this trial is testing

Study to Evaluate the Efficacy and Safety of Cinryze® for the Treatment of Acute Antibody-mediated Rejection in Participants With Kidney Transplant

Who this might be right for
Acute Antibody-Mediated Rejection (AMR)
Shire 39
Very early researchEnded earlyNCT03380936
What this trial is testing

Pilot Study of Treatment for Subclinical AMR (Antibody-mediated Rejection) in Kidney Transplant Recipients

Who this might be right for
Kidney Transplant Rejection
University of Colorado, Denver 4
Testing effectiveness (Phase 2)UnknownNCT02563340
What this trial is testing

Effect of BM-MSCs on Chronic AMR After Kidney Transplantation

Who this might be right for
Kidney Transplantation
First Affiliated Hospital, Sun Yat-Sen University 60
Large-scale testing (Phase 3)Ended earlyNCT03994783
What this trial is testing

Transplant Antibody-Mediated Rejection: Guiding Effective Treatments

Who this might be right for
Kidney Transplant RejectionAntibody-mediated Rejection
Imperial College London 3
Testing effectiveness (Phase 2)Ended earlyNCT01399593
What this trial is testing

Safety & Efficacy of Eculizumab to Prevent AMR in Living Donor Kidney Transplant Recipients Requiring Desensitization

Who this might be right for
Antibody Mediated Rejection
Alexion Pharmaceuticals, Inc. 102

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation